 Antiviral Agents
"Antiviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
| Descriptor ID |
D000998
|
| MeSH Number(s) |
D27.505.954.122.388
|
| Concept/Terms |
Antiviral Agents- Antiviral Agents
- Agents, Antiviral
- Antiviral Drugs
- Drugs, Antiviral
- Antivirals
|
Below are MeSH descriptors whose meaning is more general than "Antiviral Agents".
Below are MeSH descriptors whose meaning is more specific than "Antiviral Agents".
This graph shows the total number of publications written about "Antiviral Agents" by people in this website by year, and whether "Antiviral Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 2 | 1 | 3 | | 1981 | 0 | 1 | 1 | | 1982 | 3 | 0 | 3 | | 1983 | 1 | 0 | 1 | | 1984 | 1 | 0 | 1 | | 1985 | 1 | 0 | 1 | | 1986 | 0 | 1 | 1 | | 1987 | 3 | 0 | 3 | | 1988 | 2 | 2 | 4 | | 1989 | 0 | 1 | 1 | | 1990 | 1 | 0 | 1 | | 1991 | 2 | 0 | 2 | | 1992 | 2 | 0 | 2 | | 1993 | 3 | 0 | 3 | | 1994 | 2 | 2 | 4 | | 1995 | 9 | 2 | 11 | | 1996 | 11 | 3 | 14 | | 1997 | 9 | 4 | 13 | | 1998 | 9 | 2 | 11 | | 1999 | 9 | 4 | 13 | | 2000 | 2 | 3 | 5 | | 2001 | 7 | 5 | 12 | | 2002 | 8 | 6 | 14 | | 2003 | 7 | 7 | 14 | | 2004 | 8 | 3 | 11 | | 2005 | 6 | 4 | 10 | | 2006 | 14 | 5 | 19 | | 2007 | 12 | 7 | 19 | | 2008 | 5 | 5 | 10 | | 2009 | 6 | 6 | 12 | | 2010 | 11 | 3 | 14 | | 2011 | 17 | 6 | 23 | | 2012 | 8 | 5 | 13 | | 2013 | 9 | 4 | 13 | | 2014 | 19 | 3 | 22 | | 2015 | 21 | 5 | 26 | | 2016 | 16 | 3 | 19 | | 2017 | 9 | 6 | 15 | | 2018 | 5 | 4 | 9 | | 2019 | 9 | 6 | 15 | | 2020 | 11 | 8 | 19 | | 2021 | 11 | 10 | 21 | | 2022 | 1 | 5 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Antiviral Agents" by people in Profiles.
-
Parikh ND, Mehta N, Hoteit MA, Yang JD, John BV, Moon AM, Salgia RJ, Pillai A, Kassab I, Saeed N, Thyssen E, Nathani P, McKinney J, Chan W, Durkin C, Connor M, Alsudaney M, Konjeti R, Durand B, Nissen NN, Kim HP, Paknikar R, Rich NE, Schipper MJ, Singal AG. Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma. Cancer. 2022 10 01; 128(19):3470-3478.
-
Cohen EJ, Hochman JS, Troxel AB, Colby KA, Jeng BH. Zoster Eye Disease Study: Rationale and Design. Cornea. 2022 May 01; 41(5):562-571.
-
Odenwald MA, Paul S. Viral hepatitis: Past, present, and future. World J Gastroenterol. 2022 Apr 14; 28(14):1405-1429.
-
Tatara E, Gutfraind A, Collier NT, Echevarria D, Cotler SJ, Major ME, Ozik J, Dahari H, Boodram B. Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago. PLoS One. 2022; 17(3):e0264983.
-
Nguyen LC, Yang D, Nicolaescu V, Best TJ, Gula H, Saxena D, Gabbard JD, Chen SN, Ohtsuki T, Friesen JB, Drayman N, Mohamed A, Dann C, Silva D, Robinson-Mailman L, Valdespino A, Stock L, Suárez E, Jones KA, Azizi SA, Demarco JK, Severson WE, Anderson CD, Millis JM, Dickinson BC, Tay S, Oakes SA, Pauli GF, Palmer KE. Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses. Sci Adv. 2022 Feb 25; 8(8):eabi6110.
-
Singh DK, Aladyeva E, Das S, Singh B, Esaulova E, Swain A, Ahmed M, Cole J, Moodley C, Mehra S, Schlesinger LS, Artyomov MN, Khader SA, Kaushal D. Myeloid cell interferon responses correlate with clearance of SARS-CoV-2. Nat Commun. 2022 02 03; 13(1):679.
-
Pettit NN, Pisano J, Nguyen CT, Lew AK, Hazra A, Sherer R, Mullane KM. Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk? Clin Infect Dis. 2021 12 06; 73(11):e3990-e3995.
-
Sausen DG, Bhutta MS, Gallo ES, Dahari H, Borenstein R. Stress-Induced Epstein-Barr Virus Reactivation. Biomolecules. 2021 09 18; 11(9).
-
Gupta Y, Kumar S, Zak SE, Jones KA, Upadhyay C, Sharma N, Azizi SA, Kathayat RS. Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach. Bioorg Med Chem. 2021 10 01; 47:116393.
-
Srinivasan D, Kaul CM, Buttar AB, Nottingham FI, Greene JB. Disseminated Herpes Simplex Virus-2 (HSV-2) as a Cause of Viral Hepatitis in an Immunocompetent Host. Am J Case Rep. 2021 Aug 03; 22:e932474.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|